Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.7600-0.0600 (-2.13%)
At close: 04:00PM EDT
2.8000 +0.04 (+1.45%)
After hours: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
35,078
56,007
94,809
98,679
Other short-term investments
999
11,352
0
-
Total cash
36,077
67,359
94,809
98,679
Other current assets
3,748
4,427
4,740
3,506
Total current assets
40,035
72,009
99,677
128,449
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
603
283
635
584
Net property, plant and equipment
603
283
635
584
Total non-current assets
603
283
635
584
Total assets
40,638
72,292
100,312
129,033
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
890
275
612
244
Accrued liabilities
2,386
2,471
1,354
5,898
Total current liabilities
7,030
6,708
5,130
6,461
Non-current liabilities
Total non-current liabilities
6,303
6,000
6,205
6,000
Total liabilities
13,333
12,708
11,335
12,461
Stockholders' equity
Common stock
81
82
83
83
Retained earnings
-161,517
-127,483
-96,421
-65,991
Accumulated other comprehensive income
0
-9
0
-
Total stockholders' equity
27,305
59,584
88,977
116,572
Total liabilities and stockholders' equity
40,638
72,292
100,312
129,033